Health authorities say vaccines will mostly be donated, or, when available, be bought via negotiated deals with drugmakers, but with different budgets
A programme meant to allow pharmacists and nurses working at private pharmacies to prescribe HIV treatment or anti-HIV pills and jabs is on hold because of a drawn-out court case
Lenacapavir drug can be made for as little as R740 per year for each patient
The world has 18 months left to reach targets that all United Nations member countries signed up to in 2021
Prof Patience Mthunzi-Kufa’s work illuminates the future of healthcare
The pandemic is still claiming lives in the Indian Ocean country due to lack of HIV prevention and treatment services
About 83 out of every 100 people in our country depend on the public sector for their health care
The health of young women and girls is shaped by gender-based inequalities and violence
Zero discrimination is essential to if we are to change the fact that 7.8 million South Africans live with HIV, but 5.8 million people are on ARVs, highlighting a treatment gap
The Foundation for Professional Development has harnessed local ownership to provide quality care
Policymakers in particular need to ensure there is investment in healthcare infrastructure, public awareness and education is enhanced, screening programme quality is improved and there is equitable access to health services
The defence force only re-employed the woman after being threatened with litigation
Implementation trials start soon in South Africa to help researchers find out what will make people use a two-monthly anti-HIV jab
Bill which aims to provide universal care through a state-run fund is being reviewed by President Cyril Ramaphosa
The Nomakhayas of Nqileni in the Eastern Cape give us a case study to replicate
What can the roll-out of a two-monthly HIV prevention injection learn from how the daily anti-HIV pill was introduced? Create demand, make the jab easy to get hold of and ensure it’s not stigmatised, write Wawira Nyagah and Mitchell Warren
The health department says ViiV Healthcare’s nonprofit price for its anti-HIV jab, CAB-LA, is four times what it can pay
By 2030, the planet is likely to be warmer, undermining the fight against tuberculosis
World leaders can choose the path that ends Aids
Private pharmacies to join the management of antiretroviral treatment programme, making it easier for those who need the life-long medicine
The judge said the need to widen access to first line ART and TPT therapy on a community level was a dire need
Nhe new guidelines say anyone who has a big chance of getting infected can get access to preventive medicines
The Bulungula Incubator in the Eastern Cape has set up a medicine pick up point close to people’s homes, assisting them in sticking to their treatment
ARV drug dolutegravir will become the go-to drug in all treatment plans next year. Here are 7 things you should know
A one-man performance at The Theatre Linden reflects on the turbulent Aids crisis of the 1980s
But for how much will drugmaker ViiV Healthcare sell it to the government? We asked them in our TV programme, Health Beat
‘MTV Suga’ and its outreach component forge social and behavioural change through storytelling
The Aurum Institute is making it easier for people to get HIV prevention medication
To commemorate World Aids Day on 1 December, here are 10 movies on the subject which educated and entertained us
On current trends, the world will not meet agreed global targets on Aids, the new UNAids report, Dangerous Inequalities, shows. Urgent action to disrupt the power imbalance of patriarchy can get the Aids response on track
There has been progress in some countries but it’s still a long way off from curtailing tuberculosis on the continent
The US government has appointed the first African head of its Aids fund, Pepfar. John Nkengasong, a Cameroonian virologist